Osteoporosis Treatment Market to Hit Market Size of US$ 16.6 Billion by 2030, Says a Market Report by RationalStat
09 nov. 2023 01h21 HE
|
Rationalstat LLC
Wilmington Delaware, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Global Osteoporosis Treatment Market is valued at US$ 12.0 billion in 2023 and is expected to grow at a significant CAGR of over 4.8% over the...
Vitamin K2 Market Worth $1.16 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
16 oct. 2023 07h52 HE
|
The Insight Partners
Pune, India, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Vitamin K2, also known as menaquinone, is a part of vitamin K family. It plays an important role in keeping bones and heart healthy. MK-4 and MK-7 are...
Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research
12 oct. 2023 16h05 HE
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes
12 sept. 2023 08h30 HE
|
Entera Bio Ltd.
JERUSALEM, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX, “Entera”) and OPKO Biologics, Inc., a subsidiary of OPKO Health, Inc. (NASDAQ: OPK, “OPKO”) have entered into a Research...
Vitamin D Testing Market Size & Share to Hit USD 1.06 billion by 2031, Expanding at a CAGR of 5.8% - Exclusive Report by Transparency Market Research
11 sept. 2023 10h26 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global vitamin D testing market is projected to flourish at a CAGR of 5.8% from 2022...
Entera Bio to Participate in Upcoming Investor Conferences
05 sept. 2023 08h00 HE
|
Entera Bio Ltd.
JERUSALEM, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...
Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update
11 août 2023 16h05 HE
|
Rani Therapeutics, LLC
- Expansion of partnership with Celltrion for development of RT-105 to complement existing partnership for RT-111 - Appointment of Kate McKinley as Chief Business Officer - Presentation of three...
Entera Bio Announces Q2 2023 Financial Results and Corporate Updates
11 août 2023 16h05 HE
|
Entera Bio Ltd.
JERUSALEM, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...
Rani Therapeutics to Participate in August Investor Conferences
04 août 2023 16h05 HE
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Orthopedic Fracture Repairing Implants for Osteoporosis Market anticipated to reach US$ 4.8 billion by 2031: TMR study
31 juil. 2023 11h00 HE
|
Transparency Market Research
Wilmington, Delaware, United States, July 31, 2023 (GLOBE NEWSWIRE) -- The global market for orthopedic fracture repairing implants for osteoporosis was estimated to have acquired a market valuation...